Clinical trial
Effect of Remifentanil on Pruritus and Paresthesia Caused by Fospropofol Disodium Anesthesia
NCT07092384 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Remifentanil on Pruritus and Paresthesia Caused by Fospropofol Disodium Anesthesia
- Lead sponsor
- Tongji Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 30, 2025
- Completion date
- December 1, 2025
- Enrollment
- 265 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adverse effects, remifentanil